Live feed
Filing
SC 13D/A
SC 13D/A0001104659-23-129271·Samsara BioCapital, L.P.
Schedule 13D ownership disclosure
SYROS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 87184Q206
Event date: 2023-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,493,541
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-129271
- Form type
- SC 13D/A
- Filer
- Samsara BioCapital, L.P.
- CIK
- CIK 1699737
- Filed
- Dec 26, 2023
- Reporting period
- Dec 21, 2023
- Description
- Schedule 13D beneficial ownership